Icon (ICLR) Long-Term Investments (2010 - 2026)
Icon's (ICLR) quarterly Long-Term Investments came in at $107.2 million in Q2 2026, up 58.29% year-over-year from $67.7 million in Q2 2025, and up 10.58% quarter-over-quarter from $97.0 million in Q1 2026.
Analysis
Icon (ICLR) Long-Term Investments (2010 - 2026) Analysis & Trends
Icon (ICLR) has reported Long-Term Investments for 16 consecutive years, with $107.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Long-Term Investments rose 58.29% year-over-year to $107.2 million in Q2 2026; TTM through Jun 2026 was $107.2 million, a 58.29% increase from a year earlier, with the FY2025 full-year figure at $82.0 million, up 41.59% from the prior year.
- Long-Term Investments was $107.2 million for Q2 2026 at Icon, up from $97.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $7.1 billion in Q4 2022 and troughed at $26.0 million in Q1 2022.
- A 5-year average of $445.8 million and a median of $52.4 million in 2024 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments surged 173914.64% in 2022 and tumbled 99.34% in 2023, its largest moves.
- Over 5 years, Long-Term Investments stood at $7.1 billion in 2022, then plunged by 99.34% to $46.8 million in 2023, then grew by 23.81% to $57.9 million in 2024, then surged by 41.59% to $82.0 million in 2025, then surged by 30.69% to $107.2 million in 2026.
- The last three Long-Term Investments figures came in at $107.2 million (Q2 2026), $97.0 million (Q1 2026), and $82.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 390.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 107.23 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 206.47 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 4.04 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 14.78 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.23 Mn |
| Mar 31, 2026 | 96.97 Mn |
| Dec 31, 2025 | 82.05 Mn |
| Sep 30, 2025 | 71.28 Mn |
| Jun 30, 2025 | 67.74 Mn |
| Mar 31, 2025 | 62.16 Mn |
| Dec 31, 2024 | 57.95 Mn |
| Sep 30, 2024 | 53.72 Mn |
| Jun 30, 2024 | 50.22 Mn |
| Mar 31, 2024 | 51.16 Mn |
| Dec 31, 2023 | 46.80 Mn |
| Sep 30, 2023 | 41.79 Mn |
| Jun 30, 2023 | 35.30 Mn |
| Mar 31, 2023 | 32.05 Mn |
| Dec 31, 2022 | 7.09 Bn |
| Sep 30, 2022 | 27.93 Mn |
| Jun 30, 2022 | 26.89 Mn |
| Mar 31, 2022 | 26.00 Mn |
| Dec 31, 2021 | -4.08 Mn |
| Sep 30, 2021 | 22.76 Mn |